stockrow
Monday 9 November 2026
Export ATTO’s income statement to Excel — free account
Attovia Therapeutics, Inc.
ATTO
15.27
0.27
+1.80%
Follow ATTO
Alert me
Attovia Therapeutics, Inc. (ATTO) Return on invested capital
Attovia Therapeutics, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 0.00%. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| ATTO Attovia Therapeutics, Inc. | 0.00% |
| ACHV Achieve Life Sciences, Inc. compare | 0.00% |
| SLDB Solid Biosciences Inc. compare | 0.00% |
| SANA Sana Biotechnology, Inc. compare | 0.00% |
| CGEM Cullinan Therapeutics, Inc. compare | 0.00% |
| AURA Aura Biosciences, Inc. compare | 0.00% |
| OABI OmniAb, Inc. compare | −15.8% |
| LXRX Lexicon Pharmaceuticals, Inc. compare | −109.1% |
| DNA Ginkgo Bioworks Holdings, Inc. compare | −161.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)